Neogenomics (NEO) Free Cash Flow Growth (3y) (2013 - 2026)
Neogenomics (NEO) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 44.40% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -13.58% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.59% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -16.15% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 24.73% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 29.96% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 99.80% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -2.01% |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | 1.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78% |
| Dec 31, 2025 | -3.66% |
| Sep 30, 2025 | 26.49% |
| Jun 30, 2025 | 35.96% |
| Mar 31, 2025 | 7.15% |
| Dec 31, 2024 | 47.43% |
| Sep 30, 2024 | 59.13% |
| Jun 30, 2024 | 26.46% |
| Mar 31, 2024 | -526.74% |
| Dec 31, 2023 | -6.18% |
| Sep 30, 2023 | 40.51% |
| Jun 30, 2023 | -85.05% |
| Mar 31, 2023 | -6.00% |
| Dec 31, 2022 | 8.83% |
| Sep 30, 2022 | -60.45% |
| Jun 30, 2022 | -38.90% |
| Mar 31, 2022 | -112.31% |
| Dec 31, 2021 | -173.83% |
| Sep 30, 2021 | -65.14% |
| Jun 30, 2021 | -100.47% |